+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anaphylaxis Drug"

Anaphylaxis - Pipeline Insight, 2024 - Product Thumbnail Image

Anaphylaxis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Anaphylaxis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Anaphylaxis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Anaphylaxis - Pipeline Review, H2 2020 - Product Thumbnail Image

Anaphylaxis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
  • 13 Results (Page 1 of 1)
Loading Indicator

The Anaphylaxis Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of anaphylaxis, a severe allergic reaction. Anaphylaxis is a life-threatening condition that requires immediate medical attention. Anaphylaxis drugs are used to treat the symptoms of anaphylaxis, such as swelling, hives, and difficulty breathing. These drugs can be administered orally, intravenously, or intramuscularly. Common anaphylaxis drugs include epinephrine, antihistamines, and corticosteroids. Anaphylaxis drugs are used to treat a wide range of allergic reactions, including food allergies, insect stings, and drug allergies. These drugs are also used to treat asthma, which is a chronic condition that can cause anaphylaxis. Anaphylaxis drugs are available in both prescription and over-the-counter forms. Some companies in the Anaphylaxis Drug market include Sanofi, Mylan, Teva Pharmaceuticals, and Pfizer. These companies produce a variety of anaphylaxis drugs, including epinephrine auto-injectors, antihistamines, and corticosteroids. Show Less Read more